Latest Commercial Operations News

Renascor Resources reports significant engineering advances that increase high-value graphite production by 60%, reduce operating costs, and confirm a safer, eco-friendly purification process.

Mesoblast has commercially launched Ryoncil in the US for pediatric acute GVHD, backed by a strong cash position and advancing multiple cell therapy programs.

Austral Gold’s Q1 2025 report reveals a 15.4% drop in gold equivalent production at its Guanaco mine due to mine depletion and mill repairs, while refurbishment advances at Casposo aim to boost future output.

Challenger Gold Limited confirms steady progress on refurbishing the Casposo Toll Milling Plant in Argentina, with a second independent inspection validating the refurbishment is on track for commissioning in the second half of 2025.

MedAdvisor Limited reports a steep decline in 3Q FY25 revenue, driven by US market challenges, while accelerating cost-cutting and reaffirming full-year guidance.

EV Resources Limited advances its position in the critical antimony market with a 70% stake acquisition in Mexico’s Los Lirios project and full ownership of Utah’s historic Coyote Creek claims, setting the stage for exploration and development.

OncoSil Medical has reported a remarkable 233% increase in dose sales for Q3 FY25, alongside significant regulatory approvals and strategic expansions that position the company for accelerated growth.

ReNerve Limited reported a 39% sales increase in Q3 FY25 alongside compelling clinical validation of its NervAlign® Nerve Cuff and strategic international partnerships, positioning the company for broader market penetration.

Alexium International Group reported a challenging Q3 FY2025 with lower revenues due to softness in the US bedding market, while making significant technological strides and maintaining a solid funding position.

Streamplay Studio Limited reported a remarkable 827% increase in customer receipts for Q3 2025, driven by the full integration of Noodlecake Studios. With a robust cash balance of A$7.7 million and no debt, the company is well-positioned to accelerate growth across cloud gaming, game publishing, and emerging markets.

LTR Pharma reports strong Q1 2025 progress with FDA pre-IND meeting success, scientific acclaim for SPONTAN’s rapid absorption, and strategic launch of ROXUS to fast-track US market entry.

Invictus Energy has secured Environmental and Social Impact Assessment approval for pilot gas production at its Cabora Bassa Project, unlocking the path to commercial gas extraction and power generation in Zimbabwe.